Member Info for Celtic007

Funny, you do not own shares here FFS. £ 1 billion valuation is very conservative if all three progress well.

Chk1 news soon and toxicological studies due soon to showing long term data.

Please show us all like nicely , your shareholding . I will happily show mines.

Https://www.tipranks.com/news/company-announcements/sareum-holdings-sees-change-in-major-shareholder

Lovely these rich boys getting on ...they will do due diligence a few times

Fanny ....hello. You spring up a like a bad smell. I don't think sadoldgit implies anything. I agree that no takeover yet, as toxicity trials take time. Your agenda is clear

Exactly Luton

Exactly krone. Important milestone as will be the peer review. Matter of not IF someone makes a move, but WHEN. Move quick and get now, or let more data come in and then fight. With others.

A bit like that naked attraction dating show on channel four lol.

Thanks sadoldgit. Here here. What do you think on the news coming up regarding chk1? Would you be surprised if not on licenced? Who do you think has got it ?

Good to hear that you are on the mend pcs.

Sitting in the toilet lol 🤣

I love seeing you here Roberto, it makes my day to read your drivel.

What a horrible day holding this share FFS. Lol...

No surfie. I think our chk1 will get on licenced and that will bring a good amount in. As potnak said, this is the most advanced Clinically of all three drugs, and with good data to back it in combo therapy. I don't make predictions of price, as no value known if gets taken up.

I would be stunned if our chk1 does not get taken up by someone in January. The science speaks for itself in combo or triple therapy, umet needs that could be fast tracked are there.

How many here think it be taken up and how many that say no? Interested for views

Surfie, £4 would be close to 400 million pounds, for three compounds. Think this explanation does not suit your deramping situation. Go for it I say, sonny. You will the one drinking when that goes wrong

Brilliant post sadoldgit. Always educational. Gamma. Never seem that before. Looks weird are hitting more of the right notes in the right order unlike our other competitors.

That's two amazing reasons already why we are better than this billion pound drug. Thanks

Any low bid might work ,as other individuals interested will bid as well, as too cheap. Anything now lower than £4 a share a disgrace and cheap, considering what we have. Hopefully chk1 news soon, and hopefully as not handed back that has to be seen as a positive, but also our other competitors are doing their chk1 trials, so shows it's validation.

News soon

That's a shame warthog and sorry to hear about your day. Sareum have come a long way, but understand it's annoying waiting but it will pay off. I like all here, do get annoyed at sareum for stuff like, the RF scenario, but they are still here and looking good. Just need chk1 news to be good. Just like a lot I would love a buyout next year or two and think it is a very strong possibility. If long-term toxicity results are good, it says a lot. Why sell now and then hate yourself. We all know if we sold tomorrow, in a year this gets taken out for a few £.

The toxicology trial will take a few months as long-term , nothing anyone can do to speed it up , unless have a time machine. Then interpretation of data . Am happy with that. Looks like they have nailed it , mechanism wise. Now bring on that chk1 news .

I am happy for further validation, as it says that mechanism works. Not be one fix to all conditions

Thanks sad and hot black. Below sentence stood out for me.

We expect that the broader biopharmaceutical field will eventually recognize proteomics as the next era of precision medicine

Meg, I saw that and I left commenting on it lol. But I know someone would pick up on it lol